Groups hail Alzheimer's drug U-turn by health watchdog

Hundreds of thousands more patients in the early stages of Alzheimer's disease could get drug treatments following a U-turn by the health watchdog.

The National Institute for Health and Clinical Excellence, or NICE, is changing its guidelines for England and Wales.

It says there is evidence to justify the drugs use to treat "mild" symptoms.

Campaigners say it's a momentous decision.

Jane Hughes reports.